EDGAR Filing Documents for 0000912282-15-000243

Form 8-K - Current report:

SEC Accession No. 0000912282-15-000243

Filing Date

2015-07-16

Accepted

2015-07-16 17:26:11

Documents

Period of Report

2015-07-11

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq	Description	Document	Type	Size
1		tekmira8k_071615.htm	8-K	26858
	Complete submission text file	0000912282-15-000243.txt		28148

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 15992134
SIC: 2834 Pharmaceutical Preparations